This week Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in chemistry for developing a process to edit DNA known as CRISPR Cas-9.

Jennifer Doudna has been a key figure in the “CRISPR revolution,” having discovered the CRISPR-Cas9 genomic editing technique at her UC Berkeley lab.

Jennifer Doudna's research institute takes CRISPR to cow burps in quest to solve climate change By Helen Floersh Apr 20, 2023 3:45pm Jennifer Doudna microbiome climate change CRISPR-Cas9 ...

In a new review published Jan. 20 in Science by CRISPR pioneer Jennifer Doudna, Ph.D., and Doudna lab doctoral candidate Joy Wang, ... dubbed CRISPR-associated proteins, or Cas.

University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...

Nobel Prize winner and CRISPR DNA-editing pioneer Jennifer A. Doudna, PhD, spoke Thursday at Fred Hutch Cancer Center in Seattle.Her lecture kicked off the President’s Seminar series, presented by ...

Jennifer Doudna, the 2020 Nobel Laureate, shares her thoughts on the first decade of CRISPR genome editing, where the technology is heading next, and what it needs to get there.

Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by Dr. Jennifer Doudna who won the Nobel Prize for the life saving technology.

Owen T. Tuck, a graduate student in Jennifer Doudna’s lab at the University of California, Berkeley, thinks that the enzymes used for genome editing and engineering (such as Cas9 and Cas12 ...

Doudna earned the 2020 Nobel Prize in Chemistry for co-developing CRISPR Cas-9 genome engineering technology. The FDA-approved therapy is the first of its kind to treat sickle cell disease.

“It’s astounding,” agrees Jennifer Doudna, one of the scientists who showed in 2012 that the CRISPR–Cas system could be used to edit genomes.